| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antiphospholipid antibodies in rheumatoid arthritis: Identifying the dominoes
|
Gladd, Debbie A.
|
|
2009
|
11 |
1 |
p. 43-51
|
article
|
| 2 |
Aspirin and acetaminophen: Should they be available over the counter?
|
Brune, Kay
|
|
2009
|
11 |
1 |
p. 36-40
|
article
|
| 3 |
Atherosclerosis in autoimmune diseases
|
Matsuura, Eiji
|
|
2009
|
11 |
1 |
p. 61-69
|
article
|
| 4 |
Cardiovascular risk associated with nonsteroidal anti-inflammatory drugs
|
Hermann, Matthias
|
|
2009
|
11 |
1 |
p. 31-35
|
article
|
| 5 |
Mechanisms of antiphospholipid-induced thrombosis: Effects on the protein C system
|
Wahl, Denis
|
|
2009
|
11 |
1 |
p. 77-81
|
article
|
| 6 |
Neonatal effects of maternal antiphospholipid syndrome
|
Tincani, Angela
|
|
2009
|
11 |
1 |
p. 70-76
|
article
|
| 7 |
Outcome of aspirin treatment of antiphospholipid antibody-positive patients
|
O’Neil, Kathleen M.
|
|
2009
|
11 |
1 |
p. 1-2
|
article
|
| 8 |
Renal manifestations of the antiphospholipid syndrome
|
D’Cruz, David
|
|
2009
|
11 |
1 |
p. 52-60
|
article
|
| 9 |
The biomechanics of osteoarthritis: Implications for therapy
|
Block, Joel A.
|
|
2009
|
11 |
1 |
p. 15-22
|
article
|
| 10 |
The use of opioids in the treatment of osteoarthritis: When, why, and how?
|
Goodwin, Jeremy L. R.
|
|
2009
|
11 |
1 |
p. 5-14
|
article
|
| 11 |
WNT signaling in osteoarthritis and osteoporosis: What is the biological significance for the clinician?
|
Lodewyckx, Liesbet
|
|
2009
|
11 |
1 |
p. 23-30
|
article
|
Journal description